Selective Control Assessment of the Lower Extremities to probe the increased metabolic cost of walking after Stroke
- Conditions
- Stroke and CVA10029317
- Registration Number
- NL-OMON53894
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 36
Individuals post stroke (n = 12)
- Diagnosis of stroke at least 6 months prior to testing.
- Age between 18 and 75 years old.
- Able to walk independently for a minimum of 6 minutes without an assistive
device, manual assistance or walking aids.
- Paresis on one side of the body (hemiparesis).
Able-bodied young adults (n = 12)
- Age between 18 and 25 years old.
Able- bodied older adults (n = 12)
- Age between 50 and 75 years old.
Individuals post stroke (n = 12)
- Unable to understand the study instructions in Dutch.
- Unable to execute the study instructions.
- Having received a botulinum toxin injection in the lower extremities within
12 weeks prior to testing.
- Indications of orthopaedic, neurological, cardiorespiratory and behavioral
conditions other than stroke that may affect gait.
Healthy young and older adults (2 x n = 12)
- Unable to understand the study instructions in Dutch.
- Indications of orthopaedic, neurological, cardiorespiratory and behavioral
conditions that may affect gait.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Muscle co-activation measured by surface electromyography (Delsys 16-channel<br /><br>sEMG system, Natick, MA, USA) and energy cost measured by breath-to-breath<br /><br>analysis (K5, Cosmed, Rome, IT).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Kinematic description of the movements measured with a 10-camera motion capture<br /><br>system (Vicon Motion Systems Ltd, Yarnton, UK).</p><br>